SARS-CoV-2 Genome Sequences for Mutation and Transmission Analysis

More than 350 genome sequences of SARS-CoV-2 were shared on the GISAID platform by researchers like Christian Drosten from Charité University Hospital. The data holds clues to how the virus spread and evolved globally, including sequences from early cases in China, Germany, and Italy. The sequences represent a tiny fraction of total cases and show few telltale differences, making them easy to overinterpret.

Use Cases

• Tracing potential transmission routes based on shared mutations between sequences.
• Analyzing viral evolution by comparing genome sequences from different geographic regions.
• Building phylogenetic trees to understand the genealogy of the SARS-CoV-2 virus.

Strengths

• More than 350 genome sequences provide a basis for comparative analysis.
• Includes sequences from key early outbreak locations like China, Germany, and Italy.

Limitations

• Sequences represent a tiny fraction of total cases, limiting statistical power.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

GISAID platform, contributed by researchers including Christian Drosten at Charité University Hospital Berlin.

Collection Method

Sequenced from patient samples, such as from a German patient infected in Italy.

Time Range

Early 2020, including sequences from more than 1 month prior to 28 February.

Geography

Global, with specific mentions of China, Germany (Munich, Bavaria), and Italy.